Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013


The 8th International Conference on Genomics

30 Oct 2013 - 01 Nov 2013 - Shenzhen, China



Bookmark and Share


ICG-8 – The 8th International Conference on Genomics October 30-November 1, 2013

Vanke International Conference Center, Shenzhen, China


It's been eight years since the first ICG conference, now ICG has become one of the leading congregations to feature the latest developments in genome sciences. It successfully delivers numerous updates on on-going research projects. These projects apply the current state-of-the-art sequencing and analysis technologies to the study of human diseases and strengthen the global agriculture development.

Why you should attend ICG-8:

● Share ground-breaking research in basic and applied genomics and to advance new approaches to sequencing and bioinformatics. 

● Interact directly with top genomics luminaries and key industry leaders. 
● Attract new talent and strengthen partnerships. 
● Access to the private tours of BGI laboratory located at the Shenzhen Headquarters. 

Speakers:
Jun Wang - BGI,China
 Huanming Yang - BGI, China ​
Kathryn Holt - University of Melbourne, Australia
Justin M. O’Sullivan - Liggins Institute, University of Auckland, New Zealand ​
Mario Caccamo - Mario Caccamo
Hidewaki Nakagawa - RIKEN Center for Genomic Medicine, Japan
Jonathan Flint - Wellcome Trust Centre For Human Genetics, UK
Mick Watson - The Roslin Institute, R(D)SVS, University of Edinburgh Division of Genetics and Genomics, UK
Naoki Irie - Riken Center for Developmental Biology, Japan
Robert F. Park - The University of Sydney, Australia
Takeshi Itoh - Bioinformatics Research Unit, Japan
Ming Qi - Zhejiang University, China
Melanie Bahlo - Walter and Eliza Hall Institute of Medical Research, Australia And many more…

Register before July 15, 2013 to save up to 280 USD!
Register during July 15 and September 30, 2013 to save up to 180 USD!

Abstract Deadline: October 22, 2013


Contact Info
Email: bgi-event@service.genomics.cn
Tel: +86-755-25273340
Fax: +86-755-25031953


Further information
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Genetic Tug of War
Researchers have reported on a version of genetic parental control in mice that is more targeted, and subtle than canonical imprinting.
Error Correction Mechanism in Cell Division
Cell biologists have reported an advance in understanding the workings of an error correction mechanism that helps cells detect and correct mistakes in cell division early enough to prevent chromosome mis-segregation and aneuploidy, that is, having too many or too few chromosomes.
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study Uncovers Target for Preventing Huntington’s Disease
Scientists from Cardiff University believe that a treatment to prevent or delay the symptoms of Huntington’s disease could now be much closer, following a major breakthrough.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!